American Century Companies’s Crinetics Pharmaceuticals CRNX Stock Holding History

American Century Companies's CRNX Position: Q2 2026 in Review

American Century Companies increased its Crinetics Pharmaceuticals (CRNX) stake by 20% in Q2 2026, buying an estimated $7.8M and bringing the position to 1,262,562 shares worth $47.2M. The position accounts for 0.02% of the portfolio, ranked #882.

American Century Companies first reported a position in CRNX in Q2 2023 and has held it in 13 quarters since. The position peaked at $49.8M in Q4 2025. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

• American Century Companies held 1,262,562 shares of Crinetics Pharmaceuticals worth $47.2M as of Q2 2026.
• American Century Companies bought 209,704 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $7.8M.
• Crinetics Pharmaceuticals made up 0.02% of American Century Companies's portfolio in Q2 2026, its #882 holding.
• American Century Companies first reported a position in Crinetics Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
• American Century Companies's Crinetics Pharmaceuticals position peaked at $49.8M in Q4 2025.
• 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.